Illumina appoints Joydeep Goswami as Interim CFO
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Auld is a seasoned Financial Executive with over 30 years of relevant experience
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The commercial production in the SML was started in November 1989.
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
Enlicitide achieved all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol
The new subcutaneous autoinjector for lecanemab offers a self-administered, at-home treatment option for early-stage Alzheimer's disease
Saroglitazar was generally well tolerated, with overall adverse events generally balanced between Saroglitazar-treated and placebo-treated patients
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
Subscribe To Our Newsletter & Stay Updated